Fundamental View
Tempus AI (NASDAQ: TEMP) continues to attract attention with major partnerships in the AI and biotech space — including collaborations with AstraZeneca, Illumina, and Boehringer Ingelheim.
These deals strengthen its role in using AI for diagnostics and drug development, giving it strong long-term growth potential.
However, as a newly listed and high-growth company, short-term volatility remains likely.
Technical View
Price has made a sharp retracement into the golden OTE zone ($72–$63), overlapping a high-probability Fair Value Gap (FVG) and the weekly bullish Order Block (OB).
This zone represents a key area of interest where smart money could accumulate.
Safer traders will wait for confirmation signals within this zone, while aggressive entries could scale in early with managed risk.
Upside targets are $103 for partial profit and $155 for a full swing continuation.
Outlook
Tempus sits at a critical turning point — strong fundamentals meet a high-probability technical setup.
If the golden zone holds, a bullish reversal could unfold toward major liquidity levels.
Patience and confirmation remain key before full commitment.
⚠️ Disclaimer: This breakdown is for educational and entertainment purposes only. It is not financial advice — always DYOR and trade responsibly.
Tempus AI (NASDAQ: TEMP) continues to attract attention with major partnerships in the AI and biotech space — including collaborations with AstraZeneca, Illumina, and Boehringer Ingelheim.
These deals strengthen its role in using AI for diagnostics and drug development, giving it strong long-term growth potential.
However, as a newly listed and high-growth company, short-term volatility remains likely.
Technical View
Price has made a sharp retracement into the golden OTE zone ($72–$63), overlapping a high-probability Fair Value Gap (FVG) and the weekly bullish Order Block (OB).
This zone represents a key area of interest where smart money could accumulate.
Safer traders will wait for confirmation signals within this zone, while aggressive entries could scale in early with managed risk.
Upside targets are $103 for partial profit and $155 for a full swing continuation.
Outlook
Tempus sits at a critical turning point — strong fundamentals meet a high-probability technical setup.
If the golden zone holds, a bullish reversal could unfold toward major liquidity levels.
Patience and confirmation remain key before full commitment.
⚠️ Disclaimer: This breakdown is for educational and entertainment purposes only. It is not financial advice — always DYOR and trade responsibly.
คำจำกัดสิทธิ์ความรับผิดชอบ
ข้อมูลและบทความไม่ได้มีวัตถุประสงค์เพื่อก่อให้เกิดกิจกรรมทางการเงิน, การลงทุน, การซื้อขาย, ข้อเสนอแนะ หรือคำแนะนำประเภทอื่น ๆ ที่ให้หรือรับรองโดย TradingView อ่านเพิ่มเติมใน ข้อกำหนดการใช้งาน
คำจำกัดสิทธิ์ความรับผิดชอบ
ข้อมูลและบทความไม่ได้มีวัตถุประสงค์เพื่อก่อให้เกิดกิจกรรมทางการเงิน, การลงทุน, การซื้อขาย, ข้อเสนอแนะ หรือคำแนะนำประเภทอื่น ๆ ที่ให้หรือรับรองโดย TradingView อ่านเพิ่มเติมใน ข้อกำหนดการใช้งาน